FROM Mary Claire King
Human Genetics: Medicine, Money and Law Billions of dollars have been raised for medical research because human genes can be patented so, when breakthroughs occur, investors make money. But early this week New York Federal Judge Robert W. Sweet rocked the bio-tech industry when he ruled that human genes cannot be patented because they are products of nature, not creative invention. The decision is both applauded for liberating the promising new field of personalized genomic medicine and criticized for limiting financial incentives. We hear a variety of answers to some very challenging questions.
East Asia: President Trump's first foreign policy test Starting with North Korea's latest test of nuclear missiles, a chain of events is causing instability in Asia. Could it turn into the first real foreign policy crisis of the Trump Administration?
The President and America's infrastructure: Bait and switch? President Trump's $1 trillion infrastructure proposal may not be what it seems. We look at the prospects for much-needed improvements in roads, bridges and airports.
Is America turning its back on the world? President Trump has made no secret of his contempt for the United Nations — and he's not alone. But, will proposed cuts in US contributions be counterproductive to America's role in the world and to national security?